Evidence map›Paper›PMID 32764380›Full record

ReviewNanomaterials (Basel, Switzerland)2020

Carbon Dots for Forensic Applications: A Critical Review.

Amy Verhagen, Antonios Kelarakis

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Exploring Carbon Dots: Green Nanomaterials for Unconventional Lasing.Small (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Towards Red Emissive Systems Based on Carbon Dots.Nanomaterials (Basel, Switzerland) · 2021
    Review
  9. Carbon Dots-Based Logic Gates.Nanomaterials (Basel, Switzerland) · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amy VerhagenUCLan Research Centre for Smart Materials, School of Natural Sciences, University of Central Lancashire, Preston PR1 2HE, UK.ORCID 0000-0002-9591-2330
Antonios KelarakisUCLan Research Centre for Smart Materials, School of Natural Sciences, University of Central Lancashire, Preston PR1 2HE, UK.ORCID 0000-0002-8112-5176

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Owing to their superior fluorescence performance, inexpensive synthesis and nontoxic nature, carbon dots (C-dots) are systematically explored in a variety of applications; in this review, we outline and critically discuss recent trends with respect to their potential exploitation in criminal investigation, forensic toxicology and anti-counterfeit interventions. Capitalising on their colour-tuneable behaviour (in the sense that they adopt different colours with respect to the incident radiation), C-dot-based compositions are ideal for the visual enhancement of latent fingerprints, affording improved contrast against multicoloured and patterned backgrounds. As highly sensitive and highly selective optical nanoprobes, C-dots show excellent analytical performance in detecting biological compounds, drugs, explosives, heavy metals and poisonous reactants. In addition, benefiting from their versatile structural and chemical composition, C-dots can be incorporated into ink and polymeric formulations capable of functioning as a new generation of cost-effective barcodes and security nanotags for object authentication and anti-counterfeit applications. Translating these encouraging research outcomes into real-life innovations with significant social and economic impact requires an open, multidisciplinary approach and a close synergy between materials scientists, biologists, forensic investigators and digital engineers.

Indexed as

anti-counterfeitingcarbon dotsdrugsexplosivesfingerprintingfluorescencemolecular sensing

Identifiers

PMID32764380
PMCPMC7466432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.